Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 8 January 2009, Vol. 113, No. 2, pp. 479-487.
Prepublished online as a Blood First Edition Paper on September 30, 2008; DOI 10.1182/blood-2008-05-156612.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2008-05-156612v1
113/2/479    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verma, N. D.
Right arrow Articles by Hall, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verma, N. D.
Right arrow Articles by Hall, B. M.
Related Collections
Right arrow Transplantation
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

TRANSPLANTATION

CD4+CD25+ T cells alloactivated ex vivo by IL-2 or IL-4 become potent alloantigen-specific inhibitors of rejection with different phenotypes, suggesting separate pathways of activation by Th1 and Th2 responses

Nirupama D. Verma*,1, Karren M. Plain*,1, Masaru Nomura1, Giang T. Tran1, Catherine Robinson1, Rochelle Boyd1, Suzanne J. Hodgkinson1, and Bruce M. Hall1

1 Faculty of Medicine, University of New South Wales and Department of Medicine, Liverpool Hospital, Liverpool, Australia

CD4+CD25+Foxp3+ T cells are regulatory/suppressor cells (Tregs) that include non-antigen (Ag)–specific as well as Ag-specific Tregs. How non–Ag-specific naive CD4+CD25+ Treg develop into specific Tregs is unknown. Here, we generated adaptive Tregs by culture of naive CD4+CD25+Foxp3+ T cells with allo-Ag and either interleukin-2 (IL-2) or IL-4. Within days, IL-2 enhanced interferon-{gamma} receptor (Ifn{gamma}r) and Il-5 mRNA and IL-4 induced a reciprocal profile with de novo IL-5R{alpha} and increased IFN-{gamma} mRNA expression. Both IL-2– and IL-4–alloactivated CD4+CD25+ Tregs within 3 to 4 days of culture had enhanced capacity to induce tolerance to specific donor but not to third-party cardiac allografts. These hosts became tolerant as allografts functioned more than 250 days, with a physiologic ratio of less than 10% CD4+CD25+Foxp3+ T cells in the CD4+ population. CD4+CD25+ T cells from tolerant hosts given IL-2–cultured cells had increased Il-5 and Ifn{gamma}r mRNA. Those from hosts given IL-4–cultured cells had enhanced IL-5R{alpha} mRNA expression and IL-5 enhanced their proliferation to donor but not third-party allo-Ag. Thus, IL-2 and IL-4 activated allo-Ag–specific Tregs with distinct phenotypes that were retained in vivo. These findings suggested that T-helper 1 (Th1) and Th2 responses activate 2 pathways of adaptive Ag-specific Tregs that mediate tolerance. We propose they be known as T-suppressor 1 (Ts1) and Ts2 cells.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020